National Wealth Management Group LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 3,328 shares of the medical device company’s stock, valued at approximately $367,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Innealta Capital LLC purchased a new stake in Cooper Companies in the 2nd quarter worth $25,000. Ashton Thomas Securities LLC bought a new position in shares of Cooper Companies in the third quarter worth about $25,000. Crewe Advisors LLC grew its position in shares of Cooper Companies by 286.4% during the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after purchasing an additional 252 shares in the last quarter. Tortoise Investment Management LLC raised its stake in Cooper Companies by 75.4% during the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after purchasing an additional 169 shares during the period. Finally, Covestor Ltd lifted its holdings in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after purchasing an additional 200 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 72.01 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at $700,422.60. This represents a 78.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock valued at $27,637,427 over the last three months. 2.00% of the stock is owned by company insiders.
Analysts Set New Price Targets
Cooper Companies Stock Performance
Cooper Companies stock opened at $103.43 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The company has a market capitalization of $20.60 billion, a PE ratio of 57.46, a P/E/G ratio of 2.21 and a beta of 0.99. The company has a 50 day moving average price of $105.59 and a 200-day moving average price of $98.45. The Cooper Companies, Inc. has a fifty-two week low of $82.21 and a fifty-two week high of $112.38.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.84 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.
About Cooper Companies
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Stories
- Five stocks we like better than Cooper Companies
- Election Stocks: How Elections Affect the Stock Market
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is the Nikkei 225 index?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.